(The Hill) -- The Food and Drug Administration approved a new generic form of the abortion pill mifepristone this week, drawing upset from conservative voices.

The FDA sent a letter to Evita Solutions on Tuesday, saying that the abbreviated new drug application had met the necessary requirements and was approved.

"We have determined your Mifepristone Tablets, 200 mg to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Mifeprex (mifepristone) tablets, 200 mg, of Danco Laboratories," the FDA's letter stated.

The FDA first approved mifepristone in 2000. Mifepristone is taken in combination with the drug misoprostol to perform medical abortions, which account for about two-thirds of abortions in the U.S.

Last week, Health and Human Services Secretary Rober

See Full Page